Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS
News Apr 10, 2013
HemoCue develops, produces and markets hemoglobin, glucose and other point-of-care testing systems worldwide.
In February 2013, Quest Diagnostics announced it had entered into a definitive agreement to sell HemoCue to Radiometer, with plans to use the proceeds to repurchase approximately $300 million of Quest Diagnostics shares as part of the company's stock buyback program.
The transaction follows an announcement by Quest Diagnostics late last year that it would seek strategic alternatives for certain non-core business assets in order to concentrate on its diagnostic information services business. In December 2012, the company divested OralDNA Labs.
Comments | 0 ADD COMMENT
26th International Conference on Clinical Diabetes 2017
Dec 14 - Dec 15, 2017
3rd International Conference on Influenza and Zoonotic Diseases
Aug 21 - Aug 22, 2017